VR Logo

Accelerate Diagnostics Inc. (AXDX) download report


Healthcare | Medical Devices & Equipment

Accelerate Diagnostics Inc. (AXDX) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East.

IPO Date: 18-Nov-1996

CEO, Pres & Director: Mr. Jack Phillips

Chief Financial Officer: Mr. Steve Reichling

Listing: NASDAQ: AXDX

Country: United States

Headquarters: Tucson, AZ

Website: https://acceleratediagnostics.com

Key Facts

Market cap: $163.64 Mln

Revenue (TTM): $12.22 Mln

Earnings (TTM): $-67.65 Mln

Cash: $50.38 Mln

Total Debt: $118.97 Mln

Insider's Holding: 33.24%

Liquidity: Low

52 Week range: $0.50 - 7.19

Shares outstanding: 79,436,096

10 Years Aggregate:

  • CFO: $-403.90 Mln
  • EBITDA: $-479.73 Mln
  • Net Profit: $-555.97 Mln

Stock Performance

Time Period Accelerate Diagnostics (AXDX) S&P BSE Sensex S&P Small-Cap 600
YTD-59.392.08-8.13
1 month84.359.3214.13
3 months195.769.9412.23
1 Year-68.319.05-5.78
3 Years-50.3416.5311.43
5 Years-36.9613.769.16
10 Years-3.2412.9711.05
As on 12-Aug-2022
Year Accelerate Diagnostics (AXDX) S&P Small-Cap 600 S&P BSE Sensex
2021-31.1325.2721.99
2020-55.159.5715.75
201946.9620.8614.38
2018-55.91-9.705.87
201726.2711.7327.91
2016-3.4424.741.95
201511.99-3.36-5.03